Novartis extends commitment to help achieve final elimination of leprosy - Reuters
Novartis extends commitment to help achieve final elimination of leprosyReutersMDT consists of three drugs (rifampicin, clofazimine and dapsone), two of which (rifampicin and clofazimine) were developed in the research laboratories of Novartis in the 1980s.
India Finds Cases Of Tuberculosis Completely Resistant To Drugs - Singularity Hub
Singularity HubIndia Finds Cases Of Tuberculosis Completely Resistant To DrugsSingularity HubClofazimine and thioacetazone are two drugs that could potentially be used to treat the new form of totally resistant tuberculosis.
World Leprosy Day - Jan.29, 2012 - RTT News
World Leprosy Day - Jan.
Novartis donates $60-M multi-drug therapy for leprosy - Business Mirror
Novartis donates $60-M multi-drug therapy for leprosyBusiness MirrorMDT consists of three drugs: dapsone, rifampicin and clofazimine .
Pharma pledges more support to beat tropical diseases by 2020 - Pharma Times